Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology.
作者信息
Prieur D J, Young D M, Davis R D, Cooney D A, Homan E R, Dixon R L, Guarino A M
出版信息
Cancer Chemother Rep 3. 1973 Jan;4(1):1-39.
PMID:4634117
Abstract
摘要
相似文献
1
Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology.癌症化疗药物临床前毒理学评估程序：毒理学实验室方案
Cancer Chemother Rep 3. 1973 Jan;4(1):1-39.
2
Preclinical toxicology protocols of the Laboratory of Toxicology.毒理学实验室的临床前毒理学实验方案。
Natl Cancer Inst Monogr. 1977 Mar(45):159-77.
3
Preclinical toxicologic evaluation of tetrahydrouridine (NSC-112907) in beagle dogs and rhesus monkeys.四氢尿苷（NSC-112907）在比格犬和恒河猴中的临床前毒理学评估。
Cancer Chemother Rep 3. 1974 Sep;5(1):15-6.
4
Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.使用ICRF - 159（NSC - 129943）——一种新型抗肿瘤药物的临床前毒理学研究。
Cancer Chemother Rep 3. 1974 Sep;5(1):1-7.
5
Working session report: laboratory of toxicology.工作会议报告：毒理学实验室
Cancer Chemother Rep 3. 1972 May;3(1):63-7.
6
Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.通过大小动物毒理学对人类药物毒性进行定量预测。
Cancer Res. 1975 May;35(5):1354-64.
7
[Evaluation of antineoplastic agents and experimental animals].[抗肿瘤药物与实验动物的评估]
Jikken Dobutsu. 1978 Jan;27(1):63-9.
8
Preclinical toxicology of anticancer agents.抗癌药物的临床前毒理学
Cancer Res. 1977 Jun;37(6):1934-7.
9
Toxicology of anticancer drugs.抗癌药物的毒理学
Natl Cancer Inst Monogr. 1977 Mar(45):49-55.
10
Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man.动物和人类体内抗肿瘤化疗药物毒性剂量之间的定量关系。
Cancer Chemother Rep 3. 1972 May;3(1):13-9.
引用本文的文献
1
Antitumor drug toxicity in tumor-free and tumor-bearing mice.无瘤和荷瘤小鼠的抗肿瘤药物毒性。
Cancer Chemother Pharmacol. 1980;4(3):199-204. doi: 10.1007/BF00254019.
2
An investigation of the mouse as a model for vincristine toxicity.以小鼠为长春新碱毒性模型的研究。
Cancer Chemother Pharmacol. 1983;11(1):62-5. doi: 10.1007/BF00257421.
3
Choice of starting dose and escalation for phase I studies of antitumor agents.抗肿瘤药物I期研究起始剂量的选择与剂量递增
Cancer Chemother Pharmacol. 1992;31(3):247-50. doi: 10.1007/BF00685555.
4
[Therapeutic trials with cytostatics (author's transl)].[细胞抑制剂的治疗试验（作者译）]
Blut. 1977 Aug 29;35(2):97-102. doi: 10.1007/BF00996289.
5
Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials.十二种抗肿瘤药物的小鼠和大型动物毒理学研究：与I期临床试验起始剂量的相关性
Cancer Chemother Pharmacol. 1979;3(2):97-101. doi: 10.1007/BF00254979.
Zotero 插件